HK Stock MarketDetailed Quotes

06826 HAOHAI BIOTEC

Watchlist
  • 27.200
  • -0.500-1.81%
Noon Break Dec 5 11:50 CST
6.37BMarket Cap13.35P/E (TTM)

About HAOHAI BIOTEC Company

The company is a scientific and technological innovation enterprise that uses biomedical materials technology and genetic engineering technology for R&D, production and sales of medical devices and pharmaceuticals. It is committed to providing innovative medical products to the market through technological innovation and transformation, integration of domestic and foreign resources and large-scale production, gradually realizing import substitution of related pharmaceutical products, and becoming a leading enterprise in the field of biomedical materials. The company was listed on the main board of the Hong Kong Stock Exchange and the Science and Technology Innovation Board of the Shanghai Stock Exchange on April 30, 2015 and October 30, 2019 respectively, becoming the first “Hong Kong Stock + Science and Technology Innovation Board” biomedical listed company in the country. The Group is a technology-innovative enterprise engaged in R&D, production and sales of medical devices and pharmaceuticals. It is committed to providing innovative medical products to the market through technological innovation and transformation, integration of domestic and foreign resources and large-scale production, gradually realizing import substitution of related pharmaceutical products, and becoming a leading enterprise in the field of biomedical materials. Main products: intraocular lenses, ophthalmic viscoelastic agents, corneal shaping lenses, PRL, hyaluronic acid, orthopedic joint cavity viscoelastic supplements, anti-adhesion and hemostasis, etc. The company has received honors such as the National Science and Technology Progress Award and the second prize of the National Science and Technology Progress Award.

Company Profile

Symbol06826
Company NameHAOHAI BIOTEC
ISINCNE100001W69
Listing DateApr 30, 2015
Issue Price59.00
Shares Offered40.00M share(s)
FoundedJan 24, 2007
Registered AddressChina
Chairmanyongtai hou
Secretarymingjingtianmin zhao
Audit InstitutionErnst & Young
Company CategoryMainland registration of Mainland Individuals control
Registered OfficeNo. 5 Dongjing Road, Songjiang Industrial Zone, Shanghai
Head Office and Principal Place of BusinessRoom 1901, 19th floor, Lee Garden One, 33 Hysan Avenue, Causeway Bay, Hong Kong
Fiscal Year Ends12-31
Employees2179
MarketHong Kong motherboard
Phone021-52293555
Fax021-52293558
Emailinfo@3healthcare.com
BusinessPre-licensing: hazardous chemicals management; General matters: technical services, technology development, technical consulting, technical exchange, technology transfer, technology promotion, medical research and experimental development, chemical product production (excluding licensed chemical products), chemical product sales (excluding licensed chemical products), cosmetics wholesale, cosmetics retail; general matters (registration required): Class II medical device sales, import and export of goods, technology import and export; Post-licensing: Class II medical device production, Class III medical device production, Class III medical device management, pharmaceutical production , import and export of pharmaceuticals, contract production of pharmaceuticals. (Projects requiring approval according to law can only carry out business activities after approval by the relevant departments).

Company Executives

  • Name
  • Position
  • Salary
  • yongtai hou
  • Presidencies, Executive Director, Strategy Committee Members, Nomination Committee Members
  • 2.29M
  • jianying wu
  • Executive Director, General Manager, Strategy Committee Members, Remuneration Committee Members
  • 2.46M
  • yiyi chen
  • Executive Director
  • 1.65M
  • minjie tang
  • Executive Director, Chief Financial Officer
  • 1.84M
  • jie you
  • Non-executive Directors, Chairman of the Strategy Committee, Audit Committee Members, Nomination Committee Members
  • --
  • ming huang
  • Non-executive Directors, Remuneration Committee Members, Strategy Committee Members, Authorized Representative
  • 126.00K
  • zhihong jiang
  • Independent Non-Executive Director, Audit Committee Members
  • 141.00K
  • hongbo shen
  • Independent Non-Executive Director, Chairman of the Audit Committee, Member of the Remuneration and Assessment Committee, Nomination Committee Members
  • --
  • zhi su
  • Independent Non-Executive Director, Remuneration Committee Chairman, Audit Committee Members, Nomination Committee Members
  • 126.00K
  • yushe yang
  • Independent Non-Executive Director, Strategy Committee Members
  • 126.00K
  • lei zhao
  • Independent Non-Executive Director, Chairman of the Nomination Committee, Audit Committee Members, Remuneration Committee Members
  • 126.00K
  • yuanzhong liu
  • Chairman of the Supervisory Board, Shareholder Supervisors
  • --
  • qing yang
  • Independent Auditors
  • 126.00K
  • yuejun tang
  • Independent Auditors
  • 126.00K
  • zhangzheng wei
  • Employee Representative Supervisor
  • 1.09M
  • xiao song
  • Employee Representative Supervisor
  • 624.00K
  • caixia ren
  • Deputy General Manager
  • --
  • wenbin wang
  • Deputy General Manager
  • --
  • jundong zhang
  • Deputy General Manager
  • --
  • min tian
  • Joint Company Secretary, Board Secretary
  • --
  • mingjing zhao
  • Joint Company Secretary, Authorized Representative
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
% Chg

No Data